STOCK TITAN

Plandai Biotechnologies, Inc. Announces Termination of Asset Acquisition Agreement with EV Hotel, Updates on Status of Independent Audit

Plandai Biotechnology, Inc. (OTC: PLPL) has terminated its asset acquisition agreement with EV Hotel Corp. without incurring any penalties.

(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Rhea-AI Summary

Plandai Biotechnology, Inc. (OTC: PLPL) has terminated its asset acquisition agreement with EV Hotel Corp. without incurring any penalties. This decision was mutually agreed upon by both parties. Additionally, the Company has completed a two-year independent audit of its financial statements, which will inform future disclosures and ongoing merger efforts. Plandai seeks to generate shareholder value by merging with entities offering growth opportunities.

Loading...
Loading translation...
Argus Session date unavailable
+33.33% session move Open Argus
Details

News Market Reaction – PLPL

The recorded move for PLPL in the trading session of this news was +33.33%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SAN DIEGO, CA / ACCESSWIRE / January 4, 2023 / (OTC:PLPL) Plandai Biotechnology, Inc. ("Plandai" or the "Company") announces the termination of its previously announced asset acquisition agreement with EV Hotel Corp., a Georgia corporation. The termination was agreed to by both parties, and the Company incurred no penalties, costs, or liabilities in connection with the termination.

The Company completed its two-year independent audit of its financial statements and will use them as a basis for future disclosures and its continuing merger and acquisition efforts.

About:

Plandai Biotechnology, Inc., a Nevada corporation, is a publicly quoted shell company seeking to create value for its shareholders by merging with another entity with experienced management and opportunities for growth.

Contact:

plandai@protonmail.com

SOURCE: Plandai Biotechnology



View source version on accesswire.com:
https://www.accesswire.com/733839/Plandai-Biotechnologies-Inc-Announces-Termination-of-Asset-Acquisition-Agreement-with-EV-Hotel-Updates-on-Status-of-Independent-Audit

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What was the reason for Plandai Biotechnology's termination of the asset acquisition agreement with EV Hotel Corp?

The termination was agreed upon by both parties, and Plandai incurred no penalties or liabilities.

What is the significance of the independent audit completed by Plandai Biotechnology?

The independent audit provides a basis for future disclosures and supports the Company's ongoing merger and acquisition efforts.

How does the termination of the acquisition impact Plandai's future plans?

While the termination is a setback, Plandai continues to seek mergers with other entities that present growth opportunities.

What is Plandai Biotechnology's strategy for creating shareholder value?

Plandai aims to create shareholder value by merging with firms that have experienced management and potential for growth.

Keep reading